FOLH1 and cancer: Another group achieved similar conclusions by prospectively investigating 11 patients affected by metastatic thyroid cancer with 18F-FDG PET/CT and 68Ga-PSMA PET/MRI and reporting a great heterogeneity in FDG and PSMA uptake rates within cancer subtypes and even within individual patients.